TipRanks
Go Ultimate55% OFF

MEDICLIN (0NDG) AI Stock Analysis

Top Page

GB:0NDG

MEDICLIN

(LSE:0NDG)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue and Profitability RecoveryImproving revenue growth and a return to profitability indicate recovery in operating performance. Sustained demand across acute care, rehabilitation, and nursing services could support further earnings normalization over the next several quarters.
Negative Factors
Elevated LeverageDebt remains substantial relative to equity despite recent improvement. High leverage can constrain investment, increase sensitivity to financing costs, and reduce the company’s ability to absorb weaker occupancy, reimbursement pressure, or higher staffing expenses.

MEDICLIN (0NDG) vs. iShares MSCI United Kingdom ETF (EWC)

-20%-10%0%10%20%30%40%50%60%GB:0NDG+40.67%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
EUR 251.75M
Dividend Yield
0.79%
Average Volume (3M)
134
Price to Earnings (P/E)
8.7
Beta (1Y)
-0.09
Revenue Growth
2.94%
EPS Growth
-14.28%
Country
UK
Employees
7,048
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

MEDICLIN Business Overview & Revenue Model

Company Description

Mediclin AG is a German healthcare enterprise primarily engaged in managing hospitals across the nation. Its operations are categorized into three main segments: Post-Acute, Acute, and various other related activities. The company offers a comprehens...

MEDICLIN Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

GB:0NDG against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DE:M12DE:M1279OutperformEUR 344.06M17.9416.58%6.13%-27.50%13.64%
DE:LIKDE:LIK67NeutralEUR 153.00M27.6022.18%1.96%35.46%17.88%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
DE:RHKDE:RHK55NeutralEUR 963.91M22.503.18%1.39%4.91%11.71%
DE:MAKDE:MAK47NeutralEUR 18.98M-1.3916.80%―2.73%-1.80%

* General Sector Average

Performance Comparison

0%100%200%300%GB:0NDGDE:RHKDE:MAKDE:LIKDE:JTH0DE:M12Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:0NDG and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0NDGMEDICLIN AG5.151.4940.67%
DE:RHKRHON-KLINIKUM AG14.402.4920.95%
DE:MAKMATERNUS-Kliniken AG0.91-0.14-12.98%
DE:LIKLimes Schlosskliniken AG510.00158.8245.22%
DE:JTH0Gesundheitswelt Chiemgau AG11.40-1.20-9.52%
DE:M12M1 Kliniken AG19.565.4138.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.